Literature DB >> 23394743

Duration of untreated psychosis and cognitive functioning.

Charlotte Rapp1, Erich Studerus, Hilal Bugra, Jacqueline Aston, Corinne Tamagni, Anna Walter, Marlon Pflueger, Stefan Borgwardt, Anita Riecher-Rössler.   

Abstract

BACKGROUND: Studies examining the influence of duration of untreated psychosis (DUP) or duration of untreated illness (DUI) on cognition vary with regard to results and methods. This study is the first in this field to include an at risk mental state with later transition to psychosis (ARMS-T) sample and to analyse how the DUI relates to their cognitive functioning. Because methodological operationalization of cognitive functioning in previous studies is highly heterogeneous, we aimed to compare different approaches.
METHOD: 60 first episode psychosis (FEP) patients and 24 ARMS-T patients were examined. Associations between DUP, DUI and neurocognitive performance were tested by three different operationalizations of cognition: as the raw outcome measure of different neuropsychological tests, as outcome scores which were normed on a sample of 75 healthy participants, and as the deterioration index (DI).
RESULTS: There were no significant correlations between DUP or DUI and outcome of neuropsychological tests in both normed and raw scores. When adjusted for covariates, DUP and DUI also did not significantly predict any cognitive performance. There was no significant relationship between DUP or DUI and the DI index. However, longer DUP and DUI were significantly associated with stronger negative symptoms.
CONCLUSIONS: This study could not confirm an association between duration of untreated psychosis or duration of untreated illness and neurocognitive performance in the ARMS-T and FEP samples. This could be because schizophrenic psychoses are neurodevelopmental disorders in which most cognitive deficits exist long before the onset of psychiatric symptoms.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23394743     DOI: 10.1016/j.schres.2012.12.016

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  4 in total

1.  Detection, Assessment, and Management of Schizophrenia in an Andean Population of South America: Parkinsonism Testing and Transcranial Ultrasound as Preventive Tools.

Authors:  Mara Balda; Maria Calvó; Eduardo Padilla; Gonzalo Guerrero; Juan Molina; Nestor V Florenzano; Danielle Kamis; Javier I Escobar; C Robert Cloninger; Gabriel de Erausquin
Journal:  Focus (Am Psychiatr Publ)       Date:  2015

2.  The efficacy of targeted health agents education to reduce the duration of untreated psychosis in a rural population.

Authors:  Eduardo Padilla; Juan Molina; Danielle Kamis; Maria Calvo; Lee Stratton; Sergio Strejilevich; Gabriela Gonzalez Aleman; Gonzalo Guerrero; Mercedes Bourdieu; Horacio A Conesa; Javier I Escobar; Gabriel A de Erausquin
Journal:  Schizophr Res       Date:  2014-11-28       Impact factor: 4.939

3.  Duration of basic and attenuated-psychotic symptoms in individuals at clinical high risk for psychosis: pattern of symptom onset and effects of duration on functioning and cognition.

Authors:  Lorna Staines; Ruchika Gajwani; Joachim Gross; Andrew I Gumley; Stephen M Lawrie; Matthias Schwannauer; Frauke Schultze-Lutter; Peter J Uhlhaas
Journal:  BMC Psychiatry       Date:  2021-07-07       Impact factor: 3.630

4.  Duration of Untreated Psychosis and Brain Function during Verbal Fluency Testing in First-Episode Schizophrenia: A Near-Infrared Spectroscopy Study.

Authors:  Po-Han Chou; Wei-Hao Lin; Chih-Chien Lin; Po-Hsun Hou; Wan-Rung Li; Chia-Chun Hung; Ching-Po Lin; Tsuo-Hung Lan; Chin-Hong Chan
Journal:  Sci Rep       Date:  2015-12-10       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.